Saach Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 26-12-2024
- Paid Up Capital ₹ 0.20 M
as on 26-12-2024
- Company Age 9 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 4.75 M
as on 26-12-2024
About Saach Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.20 M.
The company currently has active open charges totaling ₹4.75 M.
Vikrant Chanana and Shikha serve as directors at the Company.
- CIN/LLPIN
U24232CH2015PTC035622
- Company No.
035622
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 Jul 2015
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Company Details
- Location
Chandigarh, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Saach Pharmaceuticals Private Limited offer?
Saach Pharmaceuticals Private Limited offers a wide range of products and services, including Common Disease Medicines, Pharmaceutical Capsules, Antibiotic Tablets & Capsules, Cefixime and Lactic Acid Bacillus Tablets, Anti Infective Drugs & Medicines, Antibiotic Injection, Pharma & Bioanalytical Services, Pharmaceutical Third Party Manufacturing, Amoxicillin drugs, Amoxicillin Potassium Clavulanate Tablet.
Who are the key members and board of directors at Saach Pharmaceuticals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vikrant Chanana  | Director | 02-Jul-2015 | Current |
| Shikha | Director | 06-Sep-2021 | Current |
Financial Performance of Saach Pharmaceuticals.
Saach Pharmaceuticals Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Saach Pharmaceuticals?
In 2017, Saach Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Canara Bank Creation Date: 19 Jul 2022 | ₹4.75 M | Open |
How Many Employees Work at Saach Pharmaceuticals?
Unlock and access historical data on people associated with Saach Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Saach Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Saach Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
